【药物名称】KF-21213
化学结构式(Chemical Structure):
参考文献No.22848
标题:Antidepressant
作者:Suzuki, F.; Shimada, J.; Ishii, A.; Nakamura, J.; Ichikawa, S.; Kitamura, S.; Koike, N. (Kyowa Hakko Kogyo Co., Ltd.)
来源:EP 0628311; JP 1994502746; WO 9401114
合成路线图解说明:

Cyclization of N,N'-diethylurea (I) with cyanoacetic acid (II) in hot acetic anhydride gives 6-amino-1,3-diethyluracil (III) which is nitrosated with NaNO2/HOAc in water to yield 6-amino-1,3-diethyl-5-nitrosouracil (IV). The reduction of (IV) with Na2S2O4 and K2CO3 in concentrated aqueous ammonia affords 5,6-diamino-1,3-diethyluracil (V), which is condensed with either 3-(3,4-dimethoxyphenyl)-2(E)-propenoyl chloride (VI) in EtOH/water or 3-(3,4-dimethoxyphenyl)-2(E)-propenoic acid (VII) and 3-[3-(diethylamino)propyl]-1-ethylcarbodiimide (EDAC) in dioxane/water to provide the corresponding amide (VIII). Cyclization of (VIII) by means of NaOH in the same solvent furnishes the xanthine derivative (IX), which is finally methylated with methyl iodide and K2CO3 in DMF.

合成路线图解说明:

Acylation of 5,6-diamino-1,3-dimethyluracil (I) with 4-methoxy-2,3-dimethylcinnamic acid (II) in the presence of EDC gave amide (III). This was then cyclized under basic conditions to afford the styryltheophylline derivative (IV). Finally, methylation of (IV) with iodomethane and K2CO3 furnished the title caffeine derivative.

参考文献No.23361
标题:Therapeutic agents for Parkinson's disease
作者:Suzuki, F.; Shimada, J.; Koike, N.; Nakamura, J.; Shiozaki, S.; Ichikawa, S.; Nonaka, H. (Kyowa Hakko Kogyo Co., Ltd.)
来源:EP 0590919; JP 1994211856; US 5484920
合成路线图解说明:

Cyclization of N,N'-diethylurea (I) with cyanoacetic acid (II) in hot acetic anhydride gives 6-amino-1,3-diethyluracil (III) which is nitrosated with NaNO2/HOAc in water to yield 6-amino-1,3-diethyl-5-nitrosouracil (IV). The reduction of (IV) with Na2S2O4 and K2CO3 in concentrated aqueous ammonia affords 5,6-diamino-1,3-diethyluracil (V), which is condensed with either 3-(3,4-dimethoxyphenyl)-2(E)-propenoyl chloride (VI) in EtOH/water or 3-(3,4-dimethoxyphenyl)-2(E)-propenoic acid (VII) and 3-[3-(diethylamino)propyl]-1-ethylcarbodiimide (EDAC) in dioxane/water to provide the corresponding amide (VIII). Cyclization of (VIII) by means of NaOH in the same solvent furnishes the xanthine derivative (IX), which is finally methylated with methyl iodide and K2CO3 in DMF.

合成路线图解说明:

Acylation of 5,6-diamino-1,3-dimethyluracil (I) with 4-methoxy-2,3-dimethylcinnamic acid (II) in the presence of EDC gave amide (III). This was then cyclized under basic conditions to afford the styryltheophylline derivative (IV). Finally, methylation of (IV) with iodomethane and K2CO3 furnished the title caffeine derivative.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us